Initiation of the first clinical trial of APG777 and APG990 combination expected to commence in 2025 with the potential for greater efficacy in atopic dermatitis and across I&I diseases SAN FRANCISCO ...
DUBLIN--(BUSINESS WIRE)--The "OX40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has been added to ...
Full Study Results Expected in Q1 2026 Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early 2026 SCOTCH PLAINS, NJ., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Navigator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results